This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Focus suppression: Difference between revisions
Jump to navigation
Jump to search
>Josikins Grammatics |
>Tracer Experience reports |
||
| (8 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
<onlyinclude> | <onlyinclude> | ||
'''Focus suppression''' (also known as '''distractability''') | '''Focus suppression''' (also known as '''distractability'''<ref name="DSM5GlossaryDistractability">{{cite journal|title=Glossary of Technical Terms|journal=Diagnostic and statistical manual of mental disorders (5th ed.)|year=2013|pages=820|doi=10.1176/appi.books.9780890425596.GlossaryofTechnicalTerms}}</ref>) is medically recognized as a decreased ability to selectively concentrate on an aspect of the environment while ignoring other things.<ref name="LlerasBuetti2013">{{cite journal|last1=Lleras|first1=Alejandro|last2=Buetti|first2=Simona|last3=Mordkoff|first3=J. Toby|title=When Do the Effects of Distractors Provide a Measure of Distractibility?|volume=59|year=2013|pages=261–315|issn=00797421|doi=10.1016/B978-0-12-407187-2.00007-1}}</ref><ref name="AhveninenJaaskelainen2000">{{cite journal|last1=Ahveninen|first1=Jyrki|last2=Jaaskelainen|first2=Iiro P.|last3=Pekkonen|first3=Eero|last4=Hallberg|first4=Anja|last5=Hietanen|first5=Marja|last6=Naatanen|first6=Risto|last7=Schroger|first7=Erich|last8=Sillanaukee|first8=Pekka|title=Increased Distractibility by Task-Irrelevant Sound Changes in Abstinent Alcoholics|journal=Alcoholism: Clinical and Experimental Research|volume=24|issue=12|year=2000|pages=1850–1854|issn=0145-6008|doi=10.1111/j.1530-0277.2000.tb01989.x}}</ref> It can be best characterized by feelings of intense distractability which can prevent one from focusing on and performing basic tasks that would usually be relatively easy to not get distracted from.<ref name="McCarthyGloria2009">{{cite journal|last1=McCarthy|first1=Danielle E.|last2=Gloria|first2=Rebecca|last3=Curtin|first3=John J.|title=Attention bias in nicotine withdrawal and under stress.|journal=Psychology of Addictive Behaviors|volume=23|issue=1|year=2009|pages=77–90|issn=1939-1501|doi=10.1037/a0014288}}</ref> This effect will often synergize with other coinciding effects such as [[motivation suppression]], [[thought deceleration]], and [[sedation]].<ref name="KowalHazekamp2014">{{cite journal|last1=Kowal|first1=Mikael A.|last2=Hazekamp|first2=Arno|last3=Colzato|first3=Lorenza S.|last4=van Steenbergen|first4=Henk|last5=van der Wee|first5=Nic J. A.|last6=Durieux|first6=Jeffrey|last7=Manai|first7=Meriem|last8=Hommel|first8=Bernhard|title=Cannabis and creativity: highly potent cannabis impairs divergent thinking in regular cannabis users|journal=Psychopharmacology|volume=232|issue=6|year=2014|pages=1123–1134|issn=0033-3158|doi=10.1007/s00213-014-3749-1}}</ref> | ||
Focus suppression is often accompanied by other coinciding effects such as [[sedation]], [[motivation suppression]], and [[creativity suppression]]. It is most commonly induced under the influence of [[dosage#common|moderate]] | Focus suppression is often accompanied by other coinciding effects such as [[sedation]], [[motivation suppression]], and [[creativity suppression]]. It is most commonly induced under the influence of [[dosage#common|moderate]] or [[dosage#heavy|heavy]] [[dosage|dosages]] of [[antipsychotic|antipsychotics]],<ref name="VigenMack2011">{{cite journal|last1=Vigen|first1=Cheryl L.P.|last2=Mack|first2=Wendy J.|last3=Keefe|first3=Richard S.E.|last4=Sano|first4=Mary|last5=Sultzer|first5=David L.|last6=Stroup|first6=T. Scott|last7=Dagerman|first7=Karen S.|last8=Hsiao|first8=John K.|last9=Lebowitz|first9=Barry D.|last10=Lyketsos|first10=Constantine G.|last11=Tariot|first11=Pierre N.|last12=Zheng|first12=Ling|last13=Schneider|first13=Lon S.|title=Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-AD|journal=American Journal of Psychiatry|volume=168|issue=8|year=2011|pages=831–839|issn=0002-953X|doi=10.1176/appi.ajp.2011.08121844}}</ref> [[benzodiazepine|benzodiazepines]], [[cannabinoid|cannabinoids]],<ref name="KowalHazekamp2014" /> and [[hallucinogen|hallucinogens]]. However, it is worth noting that [[stimulant]] compounds which primarily induce [[focus enhancement]] at light to moderate dosages will also often lead into focus suppression at their heavier dosages.<ref name="SaloNordahl2007">{{cite journal|last1=Salo|first1=Ruth|last2=Nordahl|first2=Thomas E.|last3=Natsuaki|first3=Yutaka|last4=Leamon|first4=Martin H.|last5=Galloway|first5=Gantt P.|last6=Waters|first6=Christy|last7=Moore|first7=Charles D.|last8=Buonocore|first8=Michael H.|title=Attentional Control and Brain Metabolite Levels in Methamphetamine Abusers|journal=Biological Psychiatry|volume=61|issue=11|year=2007|pages=1272–1280|issn=00063223|doi=10.1016/j.biopsych.2006.07.031}}</ref></onlyinclude> | ||
===Psychoactive substances=== | ===Psychoactive substances=== | ||
Compounds within our [[psychoactive substance index]] which may cause this effect include: | Compounds within our [[psychoactive substance index]] which may cause this effect include: | ||
{{#ask:[[Category:Psychoactive substance]][[Effect::Focus suppression]]|format=ul|Columns=2}} | {{#ask:[[Category:Psychoactive substance]][[Effect::Focus suppression]]|format=ul|Columns=2}} | ||
===Experience reports=== | |||
Annectdotal reports which describe this effect with our [[experience index]] include: | |||
{{#ask:[[Category:Experience]][[Effect::Focus suppression]]|format=ul|Columns=2}} | |||
===See also=== | ===See also=== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
| Line 16: | Line 19: | ||
* [https://en.wikipedia.org/wiki/Attentional_shift Attentional shift (Wikipedia)] | * [https://en.wikipedia.org/wiki/Attentional_shift Attentional shift (Wikipedia)] | ||
===References=== | ===References=== | ||
<references/> | <references /> | ||
[[Category:Cognitive]] [[Category:Suppression]] [[Category:Effect]] | [[Category:Cognitive]] | ||
[[Category:Suppression]] | |||
[[Category:Effect]] | |||
Latest revision as of 12:49, 6 February 2020
Focus suppression (also known as distractability[1]) is medically recognized as a decreased ability to selectively concentrate on an aspect of the environment while ignoring other things.[2][3] It can be best characterized by feelings of intense distractability which can prevent one from focusing on and performing basic tasks that would usually be relatively easy to not get distracted from.[4] This effect will often synergize with other coinciding effects such as motivation suppression, thought deceleration, and sedation.[5]
Focus suppression is often accompanied by other coinciding effects such as sedation, motivation suppression, and creativity suppression. It is most commonly induced under the influence of moderate or heavy dosages of antipsychotics,[6] benzodiazepines, cannabinoids,[5] and hallucinogens. However, it is worth noting that stimulant compounds which primarily induce focus enhancement at light to moderate dosages will also often lead into focus suppression at their heavier dosages.[7]
Psychoactive substances
Compounds within our psychoactive substance index which may cause this effect include:
- 2M2B
- Alcohol
- Blue Lotus
- Cannabis
- Clonidine
- Datura
- Dextromethorphan
- Diphenhydramine
- Haloperidol
- Ketamine
- MET
- Myristicin
- Prochlorperazine
- Quetiapine
- Risperidone
- Selective serotonin reuptake inhibitor
- Tizanidine
Experience reports
Annectdotal reports which describe this effect with our experience index include:
- Experience: 1.5g Psilocybe Cubensis - Analysis of body and mind
- Experience:100-350mg - Phenylpiracetam in daily life
- Experience:25mg - A labyrinth of organs and a storybook walk
- Experience:2mg Etizolam - Here be dragons
- Experience:4-HO-MiPT / A care free psychedelic getaway
- Experience:LSD (400ug, Oral) - An afternoon in "a" garden
- Experience:~150mg MDA(oral) - a case of mistaken identity
See also
- Responsible use
- Subjective effects index
- Focus enhancement
- Psychedelics - Subjective effects
- Dissociatives - Subjective effects
- Deliriants - Subjective effects
External links
References
- ↑ "Glossary of Technical Terms". Diagnostic and statistical manual of mental disorders (5th ed.): 820. 2013. doi:10.1176/appi.books.9780890425596.GlossaryofTechnicalTerms.
- ↑ Lleras, Alejandro; Buetti, Simona; Mordkoff, J. Toby (2013). "When Do the Effects of Distractors Provide a Measure of Distractibility?". 59: 261–315. doi:10.1016/B978-0-12-407187-2.00007-1. ISSN 0079-7421.
- ↑ Ahveninen, Jyrki; Jaaskelainen, Iiro P.; Pekkonen, Eero; Hallberg, Anja; Hietanen, Marja; Naatanen, Risto; Schroger, Erich; Sillanaukee, Pekka (2000). "Increased Distractibility by Task-Irrelevant Sound Changes in Abstinent Alcoholics". Alcoholism: Clinical and Experimental Research. 24 (12): 1850–1854. doi:10.1111/j.1530-0277.2000.tb01989.x. ISSN 0145-6008.
- ↑ McCarthy, Danielle E.; Gloria, Rebecca; Curtin, John J. (2009). "Attention bias in nicotine withdrawal and under stress". Psychology of Addictive Behaviors. 23 (1): 77–90. doi:10.1037/a0014288. ISSN 1939-1501.
- ↑ 5.0 5.1 Kowal, Mikael A.; Hazekamp, Arno; Colzato, Lorenza S.; van Steenbergen, Henk; van der Wee, Nic J. A.; Durieux, Jeffrey; Manai, Meriem; Hommel, Bernhard (2014). "Cannabis and creativity: highly potent cannabis impairs divergent thinking in regular cannabis users". Psychopharmacology. 232 (6): 1123–1134. doi:10.1007/s00213-014-3749-1. ISSN 0033-3158.
- ↑ Vigen, Cheryl L.P.; Mack, Wendy J.; Keefe, Richard S.E.; Sano, Mary; Sultzer, David L.; Stroup, T. Scott; Dagerman, Karen S.; Hsiao, John K.; Lebowitz, Barry D.; Lyketsos, Constantine G.; Tariot, Pierre N.; Zheng, Ling; Schneider, Lon S. (2011). "Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-AD". American Journal of Psychiatry. 168 (8): 831–839. doi:10.1176/appi.ajp.2011.08121844. ISSN 0002-953X.
- ↑ Salo, Ruth; Nordahl, Thomas E.; Natsuaki, Yutaka; Leamon, Martin H.; Galloway, Gantt P.; Waters, Christy; Moore, Charles D.; Buonocore, Michael H. (2007). "Attentional Control and Brain Metabolite Levels in Methamphetamine Abusers". Biological Psychiatry. 61 (11): 1272–1280. doi:10.1016/j.biopsych.2006.07.031. ISSN 0006-3223.